US 2013/0296534 A1Published application

Fusion protein having factor ix activity

AssigneeSK Chemicals Co., Ltd.

InventorsMin Sun Lee, Hun-Taek Kim, Bong-yong Lee, Mahn Hoon Park, Yun Jung Lim

Life of this patent

Estimating the term…

Abstract

Disclosed is a fusion protein comprising blood coagulation factor IX (FIX) and transferrin. The fusion protein exhibits improved specific FIX activity, as compared to native FIX, and can be useful in the treatment of FIX deficiency-associated diseases.

Claims15

Dependent claims

A fusion protein comprising human-derived factor IX (FIX) and human-derived transferrin.

Dependencies are inferred from the claim text.

Facts

Application: 13/880,239Filed 19 Oct 2011
Priority: KR 10-2010-010257220 Oct 2010
Published: 7 Nov 2013
Term ends: Not estimatedThe source records don’t support an estimate.

Classification6 codes

C07K 14/79
From animals; from humans: transferrins, e.g. lactoferrins, ovotransferrins
A61P 7/04
Drugs for disorders of the blood or the extracellular fluid: antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
C07K 14/745
From animals; from humans: blood coagulation or fibrinolysis factors
C07K 2319/00
Fusion polypeptide

Family

US 9,617,328 B2Related patent
US 2013/0296534 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results